Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Friend

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Transplantation|August 1, 1989
Campath-1M--prophylactic use after kidney transplantation. A randomized controlled clinical trialP J Friend, G Hale, H Waldmann, et al.
Transplantation Proceedings|February 1, 1987
Prophylactic use of an antilymphocyte monoclonal antibody following renal transplantation: a randomized controlled trialP J Friend, R Y Calne, G Hale, et al.
Transplantation Proceedings|March 20, 1999
Splenectomy improves survival of HDAF transgenic pig kidneys in primatesM Schmoeckel, F N Bhatti, A Zaidi, et al.
Transplantation Proceedings|September 2, 1998
Survival of life-supporting HDAF transgenic kidneys in primates is enhanced by splenectomyF N Bhatti, A Zaidi, M Schmoeckel, et al.
Transplantation|March 10, 1999
Sirolimus: a potent new immunosuppressant for liver transplantationC J Watson, P J Friend, N V Jamieson, et al.
Transplantation Proceedings|October 1, 1987
FK-506 in experimental renal allograftsD S Collier, R Calne, S Thiru, et al.
Lancet (London, England)|April 23, 1999
Intestinal transplant between two of identical tripletsR Y Calne, P J Friend, S Middleton, et al.
Archives of Disease in Childhood|October 1, 1994
Liver transplantation for hepatic cirrhosis in cystic fibrosisG Noble-Jamieson, J Valente, N D Barnes, et al.
Transplantation Proceedings|February 1, 1989
Liver transplantation in the Cambridge/King's College Hospital series--the first 400 patientsP J Friend, S Lim, M Smith, et al.
Transplantation Proceedings|December 26, 2001
beta-Galactosidase as a novel marker of ischaemic injury and a mechanism for viability assessment in liver transplantationS D St Peter, C J Imber, I Lopez, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Transplantation|August 1, 1989
Campath-1M--prophylactic use after kidney transplantation. A randomized controlled clinical trialP J Friend, G Hale, H Waldmann, et al.
Transplantation Proceedings|February 1, 1987
Prophylactic use of an antilymphocyte monoclonal antibody following renal transplantation: a randomized controlled trialP J Friend, R Y Calne, G Hale, et al.
Transplantation Proceedings|March 20, 1999
Splenectomy improves survival of HDAF transgenic pig kidneys in primatesM Schmoeckel, F N Bhatti, A Zaidi, et al.
Transplantation Proceedings|September 2, 1998
Survival of life-supporting HDAF transgenic kidneys in primates is enhanced by splenectomyF N Bhatti, A Zaidi, M Schmoeckel, et al.
Transplantation|March 10, 1999
Sirolimus: a potent new immunosuppressant for liver transplantationC J Watson, P J Friend, N V Jamieson, et al.
Transplantation Proceedings|October 1, 1987
FK-506 in experimental renal allograftsD S Collier, R Calne, S Thiru, et al.
Lancet (London, England)|April 23, 1999
Intestinal transplant between two of identical tripletsR Y Calne, P J Friend, S Middleton, et al.
Archives of Disease in Childhood|October 1, 1994
Liver transplantation for hepatic cirrhosis in cystic fibrosisG Noble-Jamieson, J Valente, N D Barnes, et al.
Transplantation Proceedings|February 1, 1989
Liver transplantation in the Cambridge/King's College Hospital series--the first 400 patientsP J Friend, S Lim, M Smith, et al.
Transplantation Proceedings|December 26, 2001
beta-Galactosidase as a novel marker of ischaemic injury and a mechanism for viability assessment in liver transplantationS D St Peter, C J Imber, I Lopez, et al.
Pageof 13